Clinical Trials Sponsored by Leslie Zun, MD

Total 28 results

Leslie Zun, MD
Teva Pharma

Unknown

Self Reported Level of Agitation of Patients Presenting to an Emergency Department

Psychiatric Issue

United States
Elie G. Abu Jawdeh, MD
University of Kentucky

Completed

Intermittent Hypoxemia and Acute Kidney Injury Study (IHAKI Study) (IHAKI)

Acute Kidney Injury | Preterm Infant | Intermittent Hypoxemia

United States
Fan Yun, MD

Completed

Apatinib for Extensive Stage Small Cell Lung Cancer After Second/Third Line Chemotherapy.

Small Cell Lung Cancer

China
Chunyan Sun, MD

Recruiting

ATG-010(Selinexor) in Combination With Chemotherapy in RRMM

Multiple Myeloma

China
Li Zhang, MD

Not yet recruiting

Phase III Study Comparing Osimertinib Monotherapy to Combination Therapy With Osimertinib,Carboplatin and Pemetrexed for Untreated Patients With Advanced Non-squamous Non-Small Cell Lung Cancer With Concurrent EGFR and TP53 Mutations (TOP)

Non-small Cell Carcinoma | EGFR Gene Mutation

China
Li Zhang, MD

Recruiting

An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese

Small Cell Lung Cancer | Lung Cancer | Durvalumab

China
Li Zhang, MD

Recruiting

Ensatinib Treat Second-generation ALK-TKI Resistance After Second-generation ALK-TKI Resistance (ERSGATR)

The Diagnosis Was ALK Positive NSCLC | Second Generation ALK-TKI is Resistant | Efficacy of Ensatinib in This Subset of Patients

China
Li Zhang, MD

Recruiting

Surufatinib Combined With Toripalimab and Chemotherapy in the Treatment of Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

China
Li Zhang, MD

Not yet recruiting

JS001 Combination Therapy in NSCLC Negative Driving Gene After First-line Chemotherapy.

Non-small Cell Lung Cancer

China
Weijing Sun, MD, FACP

Withdrawn

A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach

Adenocarcinoma | Stomach Cancer

United States
Henrique Bittencourt, MD, PhD
Michel Duval, MD; Pierre Teira, MD; Sonia Cellot, MD, PhD; Isabelle Louis, PhD; Elie... and other collaborators

Completed

Intrabone Infusion of Umbilical Cord Blood Stem Cells

Hematopoietic Stem Cell Transplantation

Canada
Weijing Sun, MD, FACP
Amgen

Completed

Phase II Study of Irinotecan and Panitumumab

Esophageal Cancer

United States
Rui-hua Xu, MD, PhD

Not yet recruiting

A Phase II Study of Surufatinib Combined With PD-L1 and mFOLFOX6 as Second-line Treatment for Advanced PRAD

Advanced Pancreatic Cancer

China
Jun Zhang, MD, PhD

Recruiting

Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)

NSCLC Stage IV | NSCLC, Recurrent

United States
Jun Gong, MD
Emmaus Medical, Inc.

Active, not recruiting

Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer

Pancreatic Cancer | Pancreatic Ductal Adenocarcinoma | Advanced Pancreatic Adenocarcinoma

United States
Jun Zhang, MD, PhD
Nilogen Oncosystems

Recruiting

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC (TUMORIN)

NSCLC | Lung Cancer | NSCLC Stage IV

United States
Jun Zhang, MD, PhD
Genentech, Inc.; Exelixis

Not yet recruiting

A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1) (Cabatezo-1)

Lung Cancer | NSCLC Stage IV | Advanced NSCLC | Metastatic NSCLC - Non-Small Cell Lung Cancer

United States
Jun Zhang, MD, PhD
Rhode Island Hospital

Recruiting

Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients (Microdurva)

NSCLC, Stage III | Locally Advanced Lung Carcinoma

United States
Jun-Lin Yi, MD

Recruiting

Optimization of Cervical Nodal CTV for Early and Medium Stage NPC

Nasopharyngeal Carcinoma

China
Jun-Lin Yi, MD

Not yet recruiting

Sintilimab Combined With Chemotherapy and SBRT in Limited Metastatic Head and Neck Squamous Cell Carcinoma (LM-HNSCC) (LM-HNSCC)

Head and Neck Squamous Cell Carcinoma | Immunotherapy | Metastases | Stereotactic Body Radiotherapy

China
Jun Zhang, MD, PhD
University of Iowa; University of Kentucky

Recruiting

Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy (Ipat-Lung)

NSCLC Stage IV | NSCLC Stage IIIB

United States
MinYoung Kim, MD, PhD
LG Life Sciences; Chong Kun Dang Pharmaceutical; CHA University; Ministry of Health...

Completed

Allogeneic UCB Therapy With EPO in Children With CP

Cerebral Palsy

Korea, Republic of
Yongtao Sun, MD, PhD
China Medical University, China; Beijing YouAn Hospital; Zhejiang University; Tang-Du... and other collaborators

Unknown

Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults

Acute HIV Infection

China
Xinhua Zhang, MD
The First Affiliated Hospital of Nanchang University; Chongqing University... and other collaborators

Recruiting

Second-line Pharmacotherapy Patterns and Outcomes of Advanced Gastrointestinal Stromal Tumor: A Real-world Study

Gastrointestinal Stromal Tumors

China
Xinhua Zhang, MD
Xijing Hospital; Chongqing University Cancer Hospital; Xiangya Hospital of Central... and other collaborators

Not yet recruiting

A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors

Gastrointestinal Stromal Tumors | Unresectable Solid Tumor | Recurrent Metastatic Malignant Neoplasm
Xinhua Zhang, MD
Xijing Hospital; Chongqing University Cancer Hospital; Xiangya Hospital of Central... and other collaborators

Not yet recruiting

Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA

Gastrointestinal Stromal Tumors | Unresectable Solid Tumor | Recurrent Metastatic Malignant Neoplasm
Anhui Shi, MD
Peking University First Hospital; Xijing Hospital; Peking University People's... and other collaborators

Completed

Twice-daily SIB Radiotherapy Versus Standard Radiotherapy for Patients With SCLC (TRISS)

Radiotherapy | Small Cell Lung Cancer Limited Stage

China
Hai-Qiang Mai,MD,PhD
Zhejiang Cancer Hospital; Fudan University; Cancer Institute and Hospital, Chinese... and other collaborators

Not yet recruiting

The Children and Adolescents Nasopharyngeal Carcinoma Survivor Study (CANPCSS)

NPC Patients

Clinical Trials Sponsored by Leslie Zun, MD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations